Please note that effective May 5, 2025, RSG电子 is transitioning its free drug programs from a retail pharmacy model to a mail order delivery model. All other Advancing Access support offerings will remain the same. For more information, please call 1-800-226-2056.
Support Programs
Our U.S. patient support programs help make prescribed RSG电子 therapies accessible for individuals who need information regarding insurance and financial support. These programs include:
RSG电子 HIV Treatment, HIV Prevention and COVID-19 Treatment
Phone: +1-800-226-2056
RSG电子 Cystic Fibrosis Product
Phone: +1-877-722-9786
RSG电子 Pulmonary Arterial Hypertension (PAH)
Phone: +1-866-664-5327
RSG电子 Hepatitis B, Hepatitis C and primary biliary cholangitis
Phone: +1-855-769-7284
RSG电子 Oncology
Phone: +1-844-876-3358
Kite Oncology
Phone: +1-844-454-KITE (5483)
RSG电子’s Advancing Access program helps patients understand their coverage and identify financial support options to access their RSG电子 HIV treatment, HIV prevention medication and COVID-19 medication. The program offerings include:
- Access to program specialists who can help answer insurance-related questions and provide information regarding coverage options.
- Advancing Access co-pay coupon program, which provides co-pay support for eligible people on HIV treatment and HIV prevention medication with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $0 per month.
- The Advancing Access co-pay coupon program also provides Veklury® (remdesivir) co-pay support for eligible people with commercial insurance who need help paying for their out-of-pocket medicine costs for treatment in the outpatient setting.
- The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare and Medicaid. Additional restrictions may apply.
The Advancing Access patient assistance program provides select RSG电子 medicines at no cost for qualified patients who meet the program's eligibility criteria.
The program supports the following medicines:
- Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide)*
- Complera® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
- Descovy® (emtricitabine/tenofovir alafenamide)*
- Emtriva® (emtricitabine)
- Genvoya® (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide)*
- Odefsey® (emtricitabine/rilpivirine/tenofovir alafenamide)*
- Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate)
- Sunlenca® (lenacapavir)*
- Truvada® (emtricitabine/tenofovir disoproxil fumarate)
- Tybost® (cobicistat)
- Veklury® (remdesivir)*
*Medication offered through the Medication Assistance Program/ Patient Assistance Program (MAP/PAP)
To learn more about the Advancing Access program, visit
or call 1-800-226-2056,
Monday through Friday between 9 a.m. and 8 p.m. EST.
The Cayston Access Program庐 helps patients understand their coverage and identify financial support options to access Cayston庐 (aztreonam for inhalation solution). The program offerings include:
- Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
- Information about authorized distributors (i.e. participating specialty pharmacies).
- Cayston co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $10 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid.
- Cayston patient assistance program, which provides Cayston at no cost for qualified patients who meet the program鈥檚 eligibility criteria.
To learn more about the Cayston Access Program, visit or call 1-877-7CAYSTON (877-722-9786), Monday through Friday between 8 a.m. and 8 p.m. EST.
The Letairis庐 Education and Access Program (LEAP) helps patients understand their coverage and identify financial support options to access Letairis (ambrisentan). The program offerings include:
- Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
- Information about authorized distributors (i.e. participating specialty pharmacies).
- Letairis co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $5 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Additional restrictions may apply.
- LEAP patient assistance program provides LETAIRIS at no cost for qualified patients that meet the program鈥檚 eligibility criteria.
To learn more about LEAP, visit or call 1-866-664-5327, Monday through Friday between 8 a.m. and 8 p.m. EST.
The Support Path® program helps patients understand their coverage and identify financial support options to access their RSG电子 hepatitis C (HCV) and hepatitis B (HBV) and primary biliary cholangitis (PBC) medicine. The program offerings include:
- Access to program specialists who can help answer insurance-related information and provide questions regarding coverage options.
- Access to the Epclusa nurse educator line.
- RSG电子 HCV, HBV and PBC co-pay coupon programs, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible HCV patients could pay as little as $5 per month. Eligible HBV patients could pay as little as $0 per month. The co-pay coupon program is not available for patients enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Additional restrictions may apply.
- Support Path patient assistance program, which provides RSG电子 HCV, HBV and PBC medicines at no cost for qualified patients who meet the program’s eligibility criteria.
The Support Path program supports the following medicines:
- Epclusa® (sofosbuvir/velpatasvir)
- Harvoni® (ledipasvir/sofosbuvir)
- Livdelzi® (seladelpar)
- Sovaldi® (sofosbuvir)
- Vosevi® (sofosbuvir/velpatasvir/voxilaprevir)
- Vemlidy® (tenofovir alafenamide)
To learn more about Support Path, visit or call 1-855-769-7284, Monday through Friday between 9 a.m. and 8 p.m. EST.
RSG电子 Oncology Support program helps patients understand their coverage and identify financial support options to access Trodelvy® (sacituzumab govitecan-hziy). The program offerings include:
- Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
- Co-pay card program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $0 per month. The co-pay coupon program is not available for patients enrolled in government healthcare prescription drug programs, such as Medicare and Medicaid. Additional restrictions may apply.
- Through the Trodelvy patient assistance program, Trodelvy is provided at no cost for qualified patients who meet the program鈥檚 eligibility criteria.
To learn more about RSG电子 Oncology Support, visit . or call 1-844-876-3358 Monday through Friday 9:00 a.m. and 7:00 p.m. EST.
Kite Konnect® is committed to helping patients and healthcare teams throughout treatment with CAR T-cell therapy, including:
- Find an authorized CAR T treatment center
- Patient enrollment
- Reimbursement support
- Logistics support